Mutated antithrombins, a process for preparing the same and their use as drugs
US8822654B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 15, 2010 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | May 29, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/745
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a composition including of at least a mutated antithrombin
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.